Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19.3M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
78.1M
-
Shares change
-
+78.1M
-
Total reported value, excl. options
-
$1.27B
-
Value change
-
+$1.27B
-
Number of buys
-
51
-
Price
-
$16.24
Significant Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q2 2021
51 filings reported holding LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.1M shares
.
Largest 10 shareholders include MWG Management Ltd. (20.3M shares), Apoletto Ltd (15.2M shares), Foresite Capital Management IV, LLC (13.3M shares), Alphabet Inc. (5.87M shares), SB Management Ltd (3.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.5M shares), SC CHINA HOLDING Ltd (2.44M shares), HHLR ADVISORS, LTD. (2.35M shares), VANGUARD GROUP INC (1.75M shares), and Board of Trustees of The Leland Stanford Junior University (1.65M shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.